Help
RSS
API
Feed
Maltego
Contact
Domain > dolon.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2025-04-22
104.21.86.112
(
ClassC
)
2026-02-14
172.67.218.147
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Sun, 04 Aug 2024 11:33:43 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Sun, 04 Aug 2024 12:33:43 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Sun, 04 Aug 2024 11:33:44 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-alivevary: Accept-Encoding,Cookielast-modified: Sun, 04 Aug 2024 11:26 !doctype html>html langen-GB classno-js> head>style>img.lazy{min-height:1px}/style>link relpreload hrefhttps://dolon.com/wp-content/plugins/w3-total-cache/pub/js/lazyload.min.js?x86566 asscript> meta charsetUTF-8> title>Dolon | Rare diseases strategic pricing and market access consultancy/title> link href//www.google-analytics.com reldns-prefetch> link hrefhttps://dolon.com/wp-content/themes/dolon/img/icons/favicon.ico?x86566 relshortcut icon> link hrefhttps://dolon.com/wp-content/themes/dolon/img/icons/touch.png?x86566 relapple-touch-icon-precomposed> meta http-equivX-UA-Compatible contentIEedge,chrome1> meta nameviewport contentwidthdevice-width, initial-scale1.0> meta namedescription contentWe specialise in strategic pricing and market access for rare and severe diseases> !-- custom fonts --> script typetext/javascript srchttps://use.typekit.net/xoz2fln.js asyncasync>/script> script>try{Typekit.load({ async: true });}catch(e){}/script> script typetext/javascript src//fast.fonts.net/jsapi/347b1830-92bf-4540-9eeb-617c830c26b5.js asyncasync>/script> meta namerobots contentindex, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1 /> meta namedescription contentTreatments for rare diseases face unique challenges in getting to market. Companies developing rare disease treatments need a specialised approach to prepare for pricing and reimbursement negotiations globally. At Dolon, we specialise in strategic pricing and market access for rare and severe diseases. /> link relcanonical hrefhttps://dolon.com/ /> meta propertyog:locale contenten_GB /> meta propertyog:type contentwebsite /> meta propertyog:title contentDolon | Rare diseases strategic pricing and market access consultancy /> meta propertyog:description contentTreatments for rare diseases face unique challenges in getting to market. Companies developing rare disease treatments need a specialised approach to prepare for pricing and reimbursement negotiations globally. At Dolon, we specialise in str
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]